Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity ...
WHO-led trials on remdesivir, hydroxychloroquine, lopinavir, and interferon for Covid-19 showed no significant reduction in mortality, ventilation initiation, or hospital stay duration among 11,330 hospitalized patients across 30 countries.
Related Clinical Trials
Reference News
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity ...
WHO-led trials on remdesivir, hydroxychloroquine, lopinavir, and interferon for Covid-19 showed no significant reduction in mortality, ventilation initiation, or hospital stay duration among 11,330 hospitalized patients across 30 countries.